Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.7K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.7K
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

7.6K
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
7.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

718
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
718
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

603
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
603
Antimicrobial Proteins01:23

Antimicrobial Proteins

11.9K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
11.9K
Microorganisms in Agriculture and Food industry01:27

Microorganisms in Agriculture and Food industry

763
Microorganisms play a crucial role in agriculture and the food industry, contributing to soil fertility, crop protection, and food production. Their functions range from nitrogen fixation and biopesticide production to fermentation and food preservation, making them indispensable to sustainable farming and food safety.Role in AgricultureNitrogen-fixing bacteria, such as Rhizobium (symbiotic) and Azotobacter (free-living), convert atmospheric nitrogen into ammonia through biological nitrogen...
763

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.

Journal of the neurological sciences·2026
Same author

Innate immunity and biomarkers of multiple sclerosis relapse versus remission.

Autoimmunity reviews·2026
Same author

The metabolic, microbial and immunological demands of pneumococcal colonisation.

PLoS pathogens·2025
Same author

Characterisation of the expression of P2X7 receptor, cancer stem cell markers and immunological mediators in human high-grade gliomas.

BMC neuroscience·2025
Same author

Purinergic P2X receptor 7 (P2X7R) inhibition induced cytotoxicity in glioblastoma.

PloS one·2025
Same author

Peripheral cytokine and monocyte phenotype associations in drug-resistant epilepsy.

Scientific reports·2025

Related Experiment Video

Updated: Nov 6, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

13.4K

Microbiota-mediated protection against antibiotic-resistant pathogens.

Rekha B Panwar1, Richard P Sequeira1, Thomas B Clarke2

  • 1MRC Centre for Molecular Bacteriology and Infection, Department of Infectious Disease, Imperial College London, London, UK.

Genes and Immunity
|May 5, 2021
PubMed
Summary

The gut microbiota protects against infections by pathogens like Klebsiella pneumoniae. Understanding specific protective microbes and mechanisms is key to developing safer alternatives to fecal microbiota transplantation.

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.1K
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:34

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

1000

Related Experiment Videos

Last Updated: Nov 6, 2025

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

13.4K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.1K
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:34

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

1000

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • The human microbiota is a crucial defense against pathogenic microbes.
  • Antibiotic use disrupts the microbiota, increasing susceptibility to infections.
  • Fecal microbiota transplantation (FMT) can restore protective microbes but has risks.

Purpose of the Study:

  • To review evidence on specific microbiota members protecting against antibiotic-resistant pathogens.
  • To explore mechanisms by which the microbiota prevents pathogen colonization.
  • To identify refined strategies for harnessing microbiota-derived protection.

Main Methods:

  • Review of clinical and experimental studies.
  • Analysis of evidence on microbiota-pathogen interactions.
  • Focus on antibiotic-resistant pathogens: Klebsiella pneumoniae, vancomycin-resistant enterococci, and Clostridioides difficile.

Main Results:

  • Specific commensal microbes confer protection against targeted pathogens.
  • Mechanisms include immune priming, metabolic competition, and direct antagonism.
  • Disruption of microbiota by antibiotics is a significant risk factor.

Conclusions:

  • Detailed knowledge of protective microbes and mechanisms is essential.
  • This knowledge can guide the development of safer, targeted microbiota-based therapies.
  • Harnessing microbiota power without FMT drawbacks is a key goal.